2023-02-02 2023-02-02 , online online, 1,190 € zzgl. MwSt. Ilona Krug https://www.forum-institut.de/seminar/23022000-market-access-in-germany-austria-and-switzerland/referenten/23/23_02/23022000-seminar-market-access-d-a-ch-region_krug-ilona.jpg Market Access in Germany, Austria and Switzerland

HTA and reimbursement in Austria, Switzerland and Germany - hands- on experiences guaranteed

Topics
  • Reimbursement system in Austria, Switzerland and Germany
  • Cooperation with payers, insurance doctors
  • Early access agreements
  • HTA requirements and launch sequence


Who should attend
This seminar focuses on the needs of those working in market access and healthcare management in the German-speaking region. Those in charge of HTA or reimbursement negotiations will benefit most from this seminar.
Aims and objectives
This seminar focuses on HTA and reimbursement in Austria, Switzerland and Germany. It therefore helps to assess similarities among and differences between the countries and to find the perfect launch sequence for your product. As well as reimbursement and contracting models, the focus is on HTA contracting to ensure a direct, practical reference.
Your benefit

  • In-depth information on HTA and reimbursement in the whole German-speaking region
  • HTA contracting in this region as part of a hands-on workshop to improve knowledge transfer
  • Decision support for your launch sequence

Seminar Market Access D-A-CH-Region

Market Access in Germany, Austria and Switzerland

Benefits
  • With local experts for Germany, Austria and Switzerland
  • Interactive training sessions
  • Countries in the DACH region in direct comparison
  • We follow the IMI quality criteria

Webcode 23022000

Jetzt buchen

JETZT Buchen
Referenten

Ilona Krug

Otsuka Pharma GmbH, Frankfurt, GERMANY

Senior Director Market Access

Dr. Stephan Ruckdäschel

HealthEcon AG, Basel

Managing Director
More information please click here.

Dr. Jurian Zürcher

Sharp&Gentle GmbH, Switzerland

Owner

Alles auf einen Blick

Termin

24/02/2023

24/02/2023

Zeitraum

09:00 am - 5:00 pm; You may dial in ...

09:00 am - 5:00 pm; You may dial in 30 minutes in advance

09:00 am - 5:00 pm; You may dial in 30 minutes in advance
Veranstaltungsort

online

online

Downloads
PROSPEKT
PROSPEKT
Gebühr

Veranstaltung - 1,190 € zzgl. MwSt.
The participation fee includes extensive documentation for download, certificate and access to the virtual seminar room.

Veranstaltung - 1,190 € zzgl. MwSt.
The participation fee includes extensive documentation for download, certificate and access to the virtual seminar room.

Inhouse-Angebote
Inhouse-Angebot anfordern
Inhouse-Angebot anfordern

Jetzt buchen

Ihre Kontaktperson

Dr. Henriette Wolf-Klein
Bereichsleiterin Healthcare

+49 6221 500-680
h.wolf-klein@forum-institut.de

Details

HTA and reimbursement in Austria, Switzerland and Germany - hands- on experiences guaranteed

Topics
  • Reimbursement system in Austria, Switzerland and Germany
  • Cooperation with payers, insurance doctors
  • Early access agreements
  • HTA requirements and launch sequence


Who should attend
This seminar focuses on the needs of those working in market access and healthcare management in the German-speaking region. Those in charge of HTA or reimbursement negotiations will benefit most from this seminar.
Aims and objectives

This seminar focuses on HTA and reimbursement in Austria, Switzerland and Germany. It therefore helps to assess similarities among and differences between the countries and to find the perfect launch sequence for your product. As well as reimbursement and contracting models, the focus is on HTA contracting to ensure a direct, practical reference.

Your benefit

  • In-depth information on HTA and reimbursement in the whole German-speaking region
  • HTA contracting in this region as part of a hands-on workshop to improve knowledge transfer
  • Decision support for your launch sequence

Detailed programme

09:00 am - 5:00 pm; You may dial in 30 minutes in advance

09:00 Introduction


09:15

Dr. Jurian Zürcher

Market Access in Austria
  • Stakeholders: pharmaceutical companies, social security, doctors and hospitals; pharmacies
  • National vs. decentralised authorisation: monitoring of market entry by a competitor - BASG, List of Goods, HEK agenda
  • Reimbursement system: box system (ASVG and EKO); Application for inclusion in the reimbursement code (EKO) Dossier
  • Cooperation with payers: insurance doctors / HEK
  • Reimbursement Codex vs. Austria Codex
  • Market access in the inpatient sector
  • Reference prices/EU average price procedure and the influence on your launch strategy

10:45 Break


11:00

Dr Stephan Ruckdäschel

Market Access in Switzerland
  • Reimbursement of medical products - Relevant processes and institutions
  • Reimbursement by the compulsory health and long-term care insurance (OKP): inclusion in the speciality list (SL)
  • Reimbursement on a case-by-casebasis - Practical experience
  • Financial challenge: Oncology drugs, ATMP, gene therapies
  • Managed Entry Agreements / reimbursement models
  • Cooperation with payers
  • Reference Pricing?

12:30 Lunch break


13:30

Ilona Krug

Market Access in Germany
  • AMNOG-eligible market and determination of reimbursement amount
  • Consequences of the AMNOG changes resulting from the GKV Finance stabilisation act
  • Rebate contract models in the field of innovative medicines
  • Germany: Referencing & Pricing
  • Significance of the European shopping basket
  • Experience from arbitration board decisions
  • Is Germany always the first launch country?

15:00 Break


15:15

Jurian Zürcher

HTA Contracting- hands on experience
  • Switzerland & Austria: Comparison of processes, timelines and consequences for negotiation (sharing experience in practice)
  • Yellow box vs. No-Box contracting: hands on experience
  • Focus on negotiation tactics: how to prepare for the punch?

17:00 End of seminar


This distinguishes our events

Overall score of all evaluations in 2022

Five stars on Trustpilot = Excellent

Recommendations

Generic Drugs: Market Access and Pricing in Europe

Online Seminar about Generic Drugs: Market Access and Pricing in Europe

07.02.2023, Online
Details

Medizinprodukte für Einsteiger

DAS Seminar für Berufs- und Quereinsteiger im Bereich Medizinprodukte!

08. - 09.02.2023, Online
Details

Regulatory Affairs for Pharmaceuticals in Japan

Here you will get useful information for your marketing authorisation and the CMC requirements in Japan. It includs also...

21. - 22.03.2023, Online
Details

Regulatory Affairs China and ASEAN CTD

Three experts will give you an in-depth update on your duties with regard to accepted clinical trial data, dossier submi...

14. - 15.03.2023, Online
Details

Regulatory Affairs in the US

Meet the experts Dr Ulrich Granzer and Dr Scott Oglesby and get first-hand information, hints and tips for your daily bu...

28.02. - 01.03.2023, Online
Details

Go forward

DEMO-Account e-Learning

Try out our e-Learning programmes free of charge and without any obligation.

Details
DEMO-Account e-Learning
Technical requirements

Here you can find the technical requirements for our online events that must be met.

Details
Technical requirements
Quality guaranteed!

Your feedback produced as result of 1.8 in 2021. Thank you!

Details
More on our quality criteria